• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 miR-338-3p 和 miR-105-3p 水平与糖尿病肾病患者骨代谢标志物的关系。

Relationship between serum level of miR-338-3p and miR-105-3p and bone metabolic markers in patients with diabetes nephropathy.

机构信息

Department of General Practice, Hubei NO.3 People's Hospital of Jianghan University, Hubei Province, China.

Department of Endocrinology, Hubei NO.3 People's Hospital of Jianghan University, Hubei Province, China.

出版信息

Ren Fail. 2024 Dec;46(2):2406390. doi: 10.1080/0886022X.2024.2406390. Epub 2024 Oct 8.

DOI:10.1080/0886022X.2024.2406390
PMID:39378116
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11463021/
Abstract

OBJECTIVES

Diabetic nephropathy (DN) is one of the most common and serious complications of diabetes. The purpose of this study was to explore the relationship between serum microRNA-338-3p (miR-338-3p) and miR-105-3p and bone metabolic markers in patients with DN at different stages.

METHODS

A total of 153 patients diagnosed and treated in the Department of Nephrology from July 2020 to October 2021 were selected as the study objects. According to the staging criteria of diabetic nephropathy and 24-h urinary albumin quantitative level, the patients were divided into control group (35 cases), microalbuminuria group (37 cases), clinical stage albuminuria group (27 cases) and renal failure group (54 cases). Gene expressions were measured by real-time fluorescence quantitative PCR. The correlation was analyzed by Spearman. Serum miR-338-3p and miR-150-5p in the prediction of renal failure in DN was analyzed by ROC curve.

RESULTS

The levels of urinary albumin and serum creatinine were markedly increased with the increase of DN stage ( < 0.05). Compared with the microalbuminuria group, the expression levels of serum miR-383-3p, serum miR-105-3p, 25(OH)-D, BGP and PINP were obviously decreased, but the expression of parathyroid hormone (PTH) and type I collagen (β-CTX) was largely increased in clinical proteinuria group ( < 0.05). Compared with the clinical proteinuria group, the expression levels of serum miR-383-3p, serum miR-105-3p, 25(OH)-D, BGP and PINP were largely decreased, but the expression of PTH and β-CTX was obviously increased in the renal failure group ( < 0.05). Spearman correlation results showed that serum expressions of miR-383-3p and miR-105-3p were negatively correlated with PTH and β-CTX, and positively correlated with 25(OH)-D, BGP and PINP ( < 0.05). ROC curve analysis showed that the AUC of serum miR-338-3p and miR-150-5p was 0.896 with the specificity and sensitivity of 96.66% and 73.47%, which had certain predictive value for the occurrence of renal failure in DN.

CONCLUSIONS

The expression levels of serum miR-383-3p and miR-105-3p were significantly correlated with bone metabolism markers. The combined test can provide new ideas and insights for the clinical treatment of osteoporosis in DN.

摘要

目的

糖尿病肾病(DN)是糖尿病最常见和最严重的并发症之一。本研究旨在探讨不同分期 DN 患者血清微小 RNA-338-3p(miR-338-3p)和 miR-105-3p 与骨代谢标志物的关系。

方法

选取 2020 年 7 月至 2021 年 10 月在我院肾病科诊治的 153 例患者为研究对象。根据糖尿病肾病分期标准和 24 h 尿白蛋白定量水平,将患者分为对照组(35 例)、微量白蛋白尿组(37 例)、临床蛋白尿组(27 例)和肾衰竭组(54 例)。采用实时荧光定量 PCR 法检测基因表达。采用 Spearman 分析进行相关性分析。采用 ROC 曲线分析血清 miR-338-3p 和 miR-150-5p 在预测 DN 肾衰竭中的价值。

结果

随着 DN 分期的增加,尿白蛋白和血肌酐水平显著升高( < 0.05)。与微量白蛋白尿组相比,临床蛋白尿组血清 miR-383-3p、血清 miR-105-3p、25(OH)-D、BGP 和 PINP 表达水平明显降低,甲状旁腺激素(PTH)和 I 型胶原(β-CTX)表达水平明显升高( < 0.05)。与临床蛋白尿组相比,肾衰竭组血清 miR-383-3p、血清 miR-105-3p、25(OH)-D、BGP 和 PINP 表达水平明显降低,PTH 和 β-CTX 表达水平明显升高( < 0.05)。Spearman 相关性分析结果显示,血清 miR-383-3p 和 miR-105-3p 表达与 PTH 和 β-CTX 呈负相关,与 25(OH)-D、BGP 和 PINP 呈正相关( < 0.05)。ROC 曲线分析显示,血清 miR-338-3p 和 miR-150-5p 的 AUC 为 0.896,特异性和敏感性分别为 96.66%和 73.47%,对 DN 肾衰竭的发生具有一定的预测价值。

结论

血清 miR-383-3p 和 miR-105-3p 的表达水平与骨代谢标志物显著相关。联合检测可为 DN 骨质疏松症的临床治疗提供新的思路和见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/f89a63a9e7ce/IRNF_A_2406390_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/4e2fc281f5b0/IRNF_A_2406390_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/9b8f57ebd922/IRNF_A_2406390_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/080bc95135ee/IRNF_A_2406390_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/b32aec2f9b3f/IRNF_A_2406390_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/f89a63a9e7ce/IRNF_A_2406390_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/4e2fc281f5b0/IRNF_A_2406390_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/9b8f57ebd922/IRNF_A_2406390_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/080bc95135ee/IRNF_A_2406390_F0003_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/b32aec2f9b3f/IRNF_A_2406390_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d023/11463021/f89a63a9e7ce/IRNF_A_2406390_F0005_C.jpg

相似文献

1
Relationship between serum level of miR-338-3p and miR-105-3p and bone metabolic markers in patients with diabetes nephropathy.血清 miR-338-3p 和 miR-105-3p 水平与糖尿病肾病患者骨代谢标志物的关系。
Ren Fail. 2024 Dec;46(2):2406390. doi: 10.1080/0886022X.2024.2406390. Epub 2024 Oct 8.
2
The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.人血清中miR-130b水平的变化及其与糖尿病肾病严重程度的相关性。
Diabetes Metab Res Rev. 2015 Oct;31(7):717-24. doi: 10.1002/dmrr.2659. Epub 2015 Jun 25.
3
Reduced Circulating Levels of miR-491-5p and miR-485-3p Are Associated with the Occurrence of Vertebral Fractures in Postmenopausal Women with Osteoporosis.循环 miR-491-5p 和 miR-485-3p 水平降低与绝经后骨质疏松症妇女椎体骨折的发生有关。
Genet Res (Camb). 2022 Mar 7;2022:3838126. doi: 10.1155/2022/3838126. eCollection 2022.
4
Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy.尿液沉淀物 microRNAs 可用作潜在的非侵入性生物标志物用于诊断,反映糖尿病肾病的严重程度和预后。
Nutr Diabetes. 2021 Jun 30;11(1):24. doi: 10.1038/s41387-021-00166-z.
5
MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.微小 RNA(miR)-590-3p 通过靶向糖尿病肾病中的 C-X3-C 基序趋化因子配体 1(CX3CL1)缓解高糖诱导的肾小管上皮细胞损伤。
Bioengineered. 2022 Jan;13(1):634-644. doi: 10.1080/21655979.2021.2012548.
6
Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy.血清微小 RNA152-3p 在伴有进行性肾病的 2 型糖尿病中的过表达。
Egypt J Immunol. 2020 Jun;27(2):81-92.
7
Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.差异微小RNA谱预测台湾地区糖尿病肾病的进展
Int J Med Sci. 2016 Jun 1;13(6):457-65. doi: 10.7150/ijms.15548. eCollection 2016.
8
miR-21-3p and miR-192-5p in patients with type 2 diabetic nephropathy.2 型糖尿病肾病患者中的 miR-21-3p 和 miR-192-5p。
Diagnosis (Berl). 2022 Aug 18;9(4):499-507. doi: 10.1515/dx-2022-0036. eCollection 2022 Nov 1.
9
Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy.血浆 microRNAs 在糖尿病肾病中的表达谱分析及临床意义。
J Diabetes Res. 2019 May 14;2019:5204394. doi: 10.1155/2019/5204394. eCollection 2019.
10
New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.新的糖尿病肾病风险因素:miRNA-196-3p 和 miRNA-203。
Minerva Endocrinol (Torino). 2022 Sep;47(3):314-324. doi: 10.23736/S2724-6507.20.03204-6. Epub 2020 Dec 17.

本文引用的文献

1
CircRBM23 regulates the switch between osteogenesis and adipogenesis of mesenchymal stem cells via sponging miR-338-3p.环状 RNA 结合蛋白 23 通过海绵吸附 miR-338-3p 调控间充质干细胞成骨分化和脂向分化的转换。
Clin Sci (Lond). 2023 Mar 31;137(6):495-510. doi: 10.1042/CS20220833.
2
MiR-338-3p Is a Biomarker in Neonatal Acute Respiratory Distress Syndrome (ARDS) and Has Roles in the Inflammatory Response of ARDS Cell Models.微小RNA-338-3p是新生儿急性呼吸窘迫综合征(ARDS)的生物标志物,并在ARDS细胞模型的炎症反应中发挥作用。
Acta Med Okayama. 2022 Dec;76(6):635-643. doi: 10.18926/AMO/64113.
3
Hsa-miR-150-5p inhibits Wnt-β-catenin signaling in human corneal epithelial stem cells.
hsa-miR-150-5p 抑制人角膜上皮干细胞中的 Wnt-β-catenin 信号通路。
Mol Vis. 2022 Aug 7;28:178-191. eCollection 2022.
4
MicroRNAs in kidney injury and disease.微小 RNA 与肾脏损伤和疾病
Nat Rev Nephrol. 2022 Oct;18(10):643-662. doi: 10.1038/s41581-022-00608-6. Epub 2022 Aug 16.
5
Stimulation of osteoclast formation and bone resorption by glucocorticoids: Synergistic interactions with the calcium regulating hormones parathyroid hormone and 1,25(OH)-vitamin D3.糖皮质激素对破骨细胞形成和骨吸收的刺激作用:与钙调节激素甲状旁腺激素和1,25(OH)-维生素D3的协同相互作用。
Vitam Horm. 2022;120:231-270. doi: 10.1016/bs.vh.2022.04.005. Epub 2022 Jul 18.
6
miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.miR-338-3p 通过靶向 PI3K/Akt 通路在苦参碱诱导的急性髓系白血病抑制中发挥重要作用。
Biomed Res Int. 2022 Jun 18;2022:9214130. doi: 10.1155/2022/9214130. eCollection 2022.
7
The metabolism of 1,25(OH)D in clinical and experimental kidney disease.1,25(OH)D 在临床和实验性肾病中的代谢。
Sci Rep. 2022 Jun 28;12(1):10925. doi: 10.1038/s41598-022-15033-9.
8
Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS.高血压合并慢性肾脏病患者小动脉的独特转录组特征鉴定出 miR-338-3p 靶向 GPX3 和 PTPRS。
J Hypertens. 2022 Jul 1;40(7):1394-1405. doi: 10.1097/HJH.0000000000003160. Epub 2022 Jun 10.
9
MiR-150-5p Overexpression in Triple-Negative Breast Cancer Contributes to the In Vitro Aggressiveness of This Breast Cancer Subtype.miR-150-5p在三阴性乳腺癌中的过表达促进了该乳腺癌亚型的体外侵袭性。
Cancers (Basel). 2022 Apr 26;14(9):2156. doi: 10.3390/cancers14092156.
10
KLF9 regulates miR-338-3p/NRCAM axis to block the progression of osteosarcoma cells.KLF9通过调控miR-338-3p/NRCAM轴来阻断骨肉瘤细胞的进展。
J Cancer. 2022 Mar 28;13(6):2029-2039. doi: 10.7150/jca.63533. eCollection 2022.